The molecules could have applications in targeted drug delivery processes, according to research lead Prof Thorfinnur Gunnlaugsson. Read more: Trinity scientists develop ‘Malteser’ molecules in biotech breakthrough
Marie Unger discusses the need for modern-day companies to bring their review processes into the 21st century. Read more: Is it time to put the annual review under the microscope?
In today’s digital-first world, the software your business relies on isn’t just a tool; it’s the backbone of your operations, often driving everything from sales and HR to finance. Consequently, […] The post Guest post: Software licensing: Reducing risks, cutting costs and securing success appeared first on Legal IT Insider.
The plans have drawn criticism from tech giant Nvidia, as well as from the Information Technology Industry Council. Read more: US announces new export rule to curb misuse of AI chips
Gatekeeping at work has the potential to negatively impact an organisation, on an individual and collective level. Read more: How to slam the door on workplace gatekeeping
Aquila Bioscience’s approach is informed by an extensive review of microbiome research originating from the International Space Station. Read more: Galway’s Aquila Biosciences and ESA partner for safer space exploration
The team are currently reviewing opportunities for another launch attempt. Read more: Technical issues delay Blue Origin rocket launch
The Commission has found that the merger can proceed if proposed requirements are met. Read more: EU approves Synopsys’ acquisition of Ansys, subject to conditions
The news comes as Vantage Data Centres, Nscale and Kyndryl have committed to investing £14bn into the UK to build AI infrastructure and create more than 13,000 jobs. Read more: OpenAI rival planned by UK government in new AI strategy
The fresh funding will be used to advance its AI offering and support its ongoing acquisition plans. Read more: Irish-founded Overhaul secures $55m